A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

NCT00209937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

675

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Insomnia

Interventions

DRUG: Gaboxadol

Sponsor

H. Lundbeck A/S